Genetic Technologies Ltd (NASDAQ:GENE)

4.14
Delayed Data
As of May 22
 +0.01 / +0.24%
Today’s Change
1.04
Today|||52-Week Range
11.00
+115.01%
Year-to-Date
Institutional investors purchased a net $2.0 million shares of GENE during the quarter ended December 2014. This may signal that the smart money is gaining interest in this company as the 17.84% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders--
Individual stakeholders--
Other institutional--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

3/06/2015HEIGHTS CAPITAL MANAGEMENT, INC.  Bought 1.1 Million shares of Genetic Technologies Ltd
3/31/2015RENAISSANCE TECHNOLOGIES LLC  Bought 592.0 Thousand shares of Genetic Technologies Ltd
3/31/2015WOLVERINE ASSET MANAGEMENT LLC  Bought 133.0 Thousand shares of Genetic Technologies Ltd

Top 10 Owners of Genetic Technologies Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Heights Capital Management, Inc.9.72%1,111,1114,911,111+1,111,111--
Renaissance Technologies LLC5.70%650,7802,876,448+591,980+1,006.77%
Wolverine Asset Management LLC1.16%133,000587,860+133,000--
Millennium Management LLC0.48%54,438240,616+54,438--
Citadel Advisors LLC0.36%40,738180,062+40,738--
BMO Capital Markets (Canada)0.13%15,00066,300+15,000--
Jane Street Capital LLC0.12%13,47759,568+13,477--
KCG Americas LLC0.10%11,31149,995+7,372+187.15%
Alpine Securities USVI LLC0.02%2,2209,81200.00%
Morgan Stanley & Co. LLC0.02%1,8228,053+1,818+45,450.00%

Top 10 Mutual Funds Holding Genetic Technologies Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change

To view my watchlist

Not a member yet?

Sign up now for a free account